Acumen Pharmaceuticals, Inc. (ABOS) Tops Q1 EPS by 3c

Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) reported Q1 EPS of ($0.48), $0.03 better than the analyst estimate of ($0.51).

For earnings history and earnings-related data on Acumen Pharmaceuticals, Inc. (ABOS) click here.

You May Also Be Interested In

• McEwen Copper seeks $1.6b in equity financing for Los Azules - Bloomberg
• EyePoint Pharmaceuticals (EYPT) call put ratio 1.4 calls to 1 put as share price up 8.9%
• Prenetics Global (PRE) Tops Q2 EPS by 18c